Tonix Pharmaceuticals Holding Corp.
(NASDAQ : TNXP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MDCOMedicines Company
1.91%49.1120.3%$153.32m
VRXValeant Pharmaceuticals International, Inc.
-1.21%22.8714.1%$134.57m
AMRNAmarin Corporation Plc Sponsored ADR
-0.59%16.841.8%$95.04m
PRGOPerrigo Co. Plc
1.73%55.246.8%$67.01m
JAZZJazz Pharmaceuticals Plc
-0.03%129.212.3%$64.09m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-4.44%128.926.2%$62.96m
SAGESAGE Therapeutics, Inc.
1.06%165.338.6%$59.63m
CTLTCatalent Inc
1.92%51.612.4%$44.61m
UTHRUnited Therapeutics Corporation
0.08%85.9914.3%$38.43m
MNKMallinckrodt Plc
1.23%2.4720.9%$37.29m
ENDPEndo International Plc
3.57%3.488.8%$34.99m
ICPTIntercept Pharmaceuticals, Inc.
0.91%69.8816.9%$32.63m
AERIAerie Pharmaceuticals, Inc.
1.83%23.336.8%$30.09m
PTLAPortola Pharmaceuticals, Inc.
0.50%30.376.7%$28.97m
ICLRICON Plc
1.01%154.724.1%$28.32m

Company Profile

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which engages in discovering and developing pharmaceutical products to treat serious neuropsychiatric conditions and biological products to improve biodefense through potential medical counter-measures. It focuses on delivering a safe and effective long-term treatment for posttraumatic stress disorder. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.